waltham
(4)
Yong Zhang and the colleagues who came back
Before he became Salary.com’s chairman and CEO, Yong Zhang helped bring the business back to its founding team. More than two dozen former colleagues returned with him.
Jennifer Honeycutt and the value of a change of mind
She began as a water chemist, then discovered she preferred leading the work to working alone at the bench. At Veralto, Jennifer Honeycutt is applying that lesson to a company built around water, packaging and the details people depend on.
Jignesh Patel and the business that starts over every morning
He bought his first hotel in 2004 with a background in technology. At JNR Management, Jignesh Patel has spent the years since bringing software discipline to a business measured one room, one shift and one night at a time.
Shengfang Jin
Shengfang Jin is a co-founder and the President and CEO of Ensem Therapeutics, a Waltham, Massachusetts biotech developing small-molecule cancer drugs by targeting protein pockets that only exist while the protein is in motion. Under Jin, Ensem built its Kinetic Ensemble platform, took its first CDK2 inhibitor into the clinic, and its ETX-636 breast cancer program earned FDA Fast Track designation. She trained at Tufts and Harvard, spent years at Agios helping deliver first-in-class cancer metabolism drugs, and then ran discovery biology at Editas before starting Ensem.